Intranasal Covid-19 Vaccines Approval: HYDERABAD: Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of BBIL, Krishna Ella said. “We will be applying for licenses and (they) should come. If everything goes well, we know by next month (August). You
The Drugs Controller General of India granted emergency use authorisation to indigenously-developed Bharat Biotech's Covaxin for children above 12 years with certain conditions on December 24.
The Indian embassy in Saudi Arabia stated on Monday that the gulf kingdom has now added Bharat Biotech's Covaxin in its list of authorised COVID-19 vaccines, bringing a huge relief to lakhs of non-resident Indians (NRIs) on the Kingdom of Saudi Arabia. "Embassy is glad to report that Indian people vaccinated with 'Covaxin' are now permitted to visit the Kingdom," the Indian